Nitin Joshi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Nitin Joshi has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Alex Hlavaty
University Grenoble Alpes, Pharmacovigilance Unit and Clinical Pharmacology Department (CIC-1406), Grenoble Alpes University Hospital, Grenoble, France (C.K., A.H.).
2 shared publications - Andrew Bate
GSK London UK
2 shared publications - Antoine Pariente
Univ. Bordeaux, INSERM, BPH, team AHeaD, U1219, Bordeaux, France
2 shared publications - Charles Khouri
Université Grenoble Alpes, INSERM U1300, HP2, and INSERM CIC1406, Grenoble, France (C.J.-B., C.K.).
2 shared publications - Emanuel Raschi
Department of Medical and Surgical Sciences University of Bologna Bologna Italy
2 shared publications - Francesco Salvo
INSERM, BPH, Team AHeaD, U1219 Université de Bordeaux Bordeaux France
2 shared publications
Latest Publications
- 5 May 2026
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 120 (1) , 26-27
Reply to “A Comment about AI Methods that May Help Advance Pharmacovigilance”
- 5 May 2026
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 120 (1) , 26-27
Reply to “A Comment about AI Methods that May Help Advance Pharmacovigilance”
- 21 December 2025
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 119 (2) , 318-321
The Rising Misuse of Pharmacovigilance Reporting Systems: A Threat to Evidence‐Based Medicine
In recent years, different national and international regulatory authorities, notably the FDA, have made their adverse event repositories publicly available, offering user‐friendly dashboards. This has led to a large increase in low‐quality, poorly reported research using adverse event reporting databases (e.g., FDA’s Adverse Event Reporting System [FAERS]). Such publications producing thousands of statistical associations erroneously presented as “safety signals” can create unscientifically grounded alarm with considerable impact on healthcare provider practices and patient behaviors.
- 21 December 2025
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 119 (2) , 318-321
The Rising Misuse of Pharmacovigilance Reporting Systems: A Threat to Evidence‐Based Medicine
In recent years, different national and international regulatory authorities, notably the FDA, have made their adverse event repositories publicly available, offering user‐friendly dashboards. This has led to a large increase in low‐quality, poorly reported research using adverse event reporting databases (e.g., FDA’s Adverse Event Reporting System [FAERS]). Such publications producing thousands of statistical associations erroneously presented as “safety signals” can create unscientifically grounded alarm with considerable impact on healthcare provider practices and patient behaviors.
- Top Cited PapersOpen Access
- 22 November 2024
- Published by Public Library of Science (PLoS) in PLOS Biology
- Vol. 22 (11) , e3002931
A call for research to address the threat of paper mills
Research paper mills are covert organizations that provide low-quality or fabricated manuscripts to paying clients. As members of the United2Act Research Working Group, we propose 5 key research questions on paper mills that require resourcing and support.
- 22 November 2024
- Published by Public Library of Science (PLoS) in PLOS Biology
- Vol. 22 (11) , e3002931
Top Cited PapersOpen AccessA call for research to address the threat of paper mills
Research paper mills are covert organizations that provide low-quality or fabricated manuscripts to paying clients. As members of the United2Act Research Working Group, we propose 5 key research questions on paper mills that require resourcing and support.